top of page
NEWS & INSIGHTS
Dive into the Biopharma Space
Stay up-to-date on major biopharma news, deeper dives into specific companies and biopharma themes, and how it all relates to biopharma partners.
FEATURED POST
Ariel Victorio
ASGCT 2024: A Look at Participating Organizations
The American Society of Gene and Cell Therapy (ASGCT) is currently in full swing, bringing together the brightest minds in gene and cell...
11 hours ago
7 FDA Approval Decisions Coming This Quarter
7 FDA approval decisions are expected by March 2025 with insights from biopharmIQs platform. Learn about them and our new Team Plan.
Jan 23
2024 Breakthrough: 9 New Cell and Gene Therapies Approvals
We've come a long way since the first monoclonal antibody, Muromonab-CD3 (OKT3) was approved in 1986. It took more than 30 years after...
Jan 9
4 Companies with FDA Approval Decisions Expected Before the End of January
We used our  biopharmIQ online platform  to identify upcoming FDA approval (PDUFA) dates for biopharma companies through the end of...
Dec 5, 2024
5 Companies with FDA Approval Decisions Expected Before the End of December
We used our  biopharmIQ online platform  to identify upcoming FDA approval (PDUFA) dates for small and mid-sized biopharma companies...
Nov 21, 2024
November PDUFA Update: 4 Approvals and 1 AdComm
November has 4 FDA approvals so far. Most recently, the FDA approved Jazz Pharmaceuticals & Zymeworks’ Ziihera (zanidatamab) and Autolus’...
Oct 24, 2024
6 companies with FDA approval decisions expected before the end of November
We used our biopharmIQ online platform to identify upcoming FDA approval (PDUFA) dates for small and mid-sized biopharma companies...
Sep 26, 2024
New Clinical Trials Alert Service And Clinical Trial Private Company Sponsors from Western U.S. (Newly Posted Trials - Q3 2024)
We used our new clinicaltrials.gov search and alerts tool, to identify companies in the western U.S. that posted new clinical trials on...
Sep 4, 2024
August 2024 PDUFAs & AdComms Recap
August was an excellent month for biopharma in terms of approvals vs. CRLs, with 8 of 10 therapeutic candidates with PDUFA dates in...
Aug 28, 2024
5 FDA Approvals for Small/Mid-sized Biopharma in Sept '24
FDA approvals are particularly important for small and mid-sized biopharma companies. Using our online platform we identified 5 FDA...
Apr 25, 2024
5 Companies with Recent/Upcoming FDA Approval Decisions
We’re always excited to find bio/pharma companies nearing their 1st therapeutic product launch! ✨ Check out these 5 companies that have...
Jun 27, 2023
New Era In Alzheimer's Treatments Brings Opportunities
BiopharmIQ Biotech Business & Corp Dev INSIGHTS Are you a CRO, CMO, or Biopharma vendor? BiopharmIQ MarketCompass is a market...
May 18, 2023
Upcoming Phase 3 Trial Initiations To Watch For
Here's some upcoming phase 3 clinical trials! *not on clintrials gov* 😉 ⚡ 89bio plans to initiate a phase 3 for Pegozafermin to treat...
bottom of page